Tokushima, Japan

Kenji Nakaya

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 7.0

ph-index = 9

Forward Citations = 240(Granted Patents)


Location History:

  • Tokushima-ken, JP (1996 - 1999)
  • Tokushima, JP (1993 - 2015)

Company Filing History:


Years Active: 1993-2015

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Kenji Nakaya: Innovator in Pharmaceutical Crystallization

Introduction

Kenji Nakaya is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical crystallization, holding a total of 14 patents. His work focuses on the development of stable and efficient pharmaceutical compositions.

Latest Patents

One of Nakaya's latest innovations is related to tetomilast polymorphs. This invention provides a tetomilast crystal that can be produced industrially in large volumes. The patent details several types of crystals, including: (1) a tetomilast hydrate crystal, (2) an anhydrous tetomilast type A crystal, (3) an anhydrous tetomilast type C crystal, (4) a tetomilast acetonitrile solvate crystal, and (5) a mixture of anhydrous tetomilast type A and type B crystals. These crystals exhibit stability towards heat and moisture, and they demonstrate excellent disintegration and dissolution properties, making them ideal for pharmaceutical applications.

Career Highlights

Kenji Nakaya is associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing the understanding and application of pharmaceutical crystallization techniques.

Collaborations

Throughout his career, Nakaya has collaborated with notable colleagues, including Michiaki Tominaga and Hidenori Ogawa. These collaborations have contributed to the success of his research and the development of new pharmaceutical products.

Conclusion

Kenji Nakaya's contributions to pharmaceutical crystallization have made a significant impact on the industry. His innovative work on tetomilast polymorphs exemplifies his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…